Skip to Content
Merck
CN

L-Fucose production by engineered Escherichia coli.

Biotechnology and bioengineering (2019-01-01)
Jing-Jing Liu, Jae Won Lee, Eun Ju Yun, Sang-Min Jung, Jin-Ho Seo, Yong-Su Jin
ABSTRACT

L-Fucose (6-deoxy-L-galactose) is a major constituent of glycans and glycolipids in mammals. Fucosylation of glycans can confer unique functional properties and may be an economical way to manufacture L-fucose. Research can extract L-fucose directly from brown algae, or by enzymatic hydrolysis of L-fucose-rich microbial exopolysaccharides. However, these L-fucose production methods are not economical or scalable for various applications. We engineered an Escherichia coli strain to produce L-fucose. Specifically, we modified the strain genome to eliminate endogenous L-fucose and lactose metabolism, produce 2'-fucosyllactose (2'-FL), and to liberate L-fucose from 2'-FL. This E. coli strain produced 16.7 g/L of L-fucose with productivity of 0.1 g·L-1 ·h-1 in a fed-batch fermentation. This study presents an efficient one-pot biosynthesis strategy to produce a monomeric form of L-fucose by microbial fermentation, making large-scale industrial production of L-fucose feasible.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-(−)-Fucose, ≥98% (GC)